Cargando…
RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019050/ https://www.ncbi.nlm.nih.gov/pubmed/35440072 http://dx.doi.org/10.1038/s41408-022-00662-0 |
| _version_ | 1784689161521856512 |
|---|---|
| author | Parrondo, Ricardo D. Sam, Keren Rasheed, Ahsan Alegria, Victoria Sher, Taimur Roy, Vivek Chanan-Khan, Asher Ailawadhi, Sikander |
| author_facet | Parrondo, Ricardo D. Sam, Keren Rasheed, Ahsan Alegria, Victoria Sher, Taimur Roy, Vivek Chanan-Khan, Asher Ailawadhi, Sikander |
| author_sort | Parrondo, Ricardo D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9019050 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90190502022-04-28 RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis Parrondo, Ricardo D. Sam, Keren Rasheed, Ahsan Alegria, Victoria Sher, Taimur Roy, Vivek Chanan-Khan, Asher Ailawadhi, Sikander Blood Cancer J Article Nature Publishing Group UK 2022-04-19 /pmc/articles/PMC9019050/ /pubmed/35440072 http://dx.doi.org/10.1038/s41408-022-00662-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Article Parrondo, Ricardo D. Sam, Keren Rasheed, Ahsan Alegria, Victoria Sher, Taimur Roy, Vivek Chanan-Khan, Asher Ailawadhi, Sikander RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis |
| title | RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis |
| title_full | RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis |
| title_fullStr | RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis |
| title_full_unstemmed | RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis |
| title_short | RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis |
| title_sort | retracted article: subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: a single center analysis |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019050/ https://www.ncbi.nlm.nih.gov/pubmed/35440072 http://dx.doi.org/10.1038/s41408-022-00662-0 |
| work_keys_str_mv | AT parrondoricardod retractedarticlesubsequentantimyelomatherapyafteridecabtagenevicleuceltreatmentinpatientswithrelapsedrefractorymultiplemyelomaasinglecenteranalysis AT samkeren retractedarticlesubsequentantimyelomatherapyafteridecabtagenevicleuceltreatmentinpatientswithrelapsedrefractorymultiplemyelomaasinglecenteranalysis AT rasheedahsan retractedarticlesubsequentantimyelomatherapyafteridecabtagenevicleuceltreatmentinpatientswithrelapsedrefractorymultiplemyelomaasinglecenteranalysis AT alegriavictoria retractedarticlesubsequentantimyelomatherapyafteridecabtagenevicleuceltreatmentinpatientswithrelapsedrefractorymultiplemyelomaasinglecenteranalysis AT shertaimur retractedarticlesubsequentantimyelomatherapyafteridecabtagenevicleuceltreatmentinpatientswithrelapsedrefractorymultiplemyelomaasinglecenteranalysis AT royvivek retractedarticlesubsequentantimyelomatherapyafteridecabtagenevicleuceltreatmentinpatientswithrelapsedrefractorymultiplemyelomaasinglecenteranalysis AT chanankhanasher retractedarticlesubsequentantimyelomatherapyafteridecabtagenevicleuceltreatmentinpatientswithrelapsedrefractorymultiplemyelomaasinglecenteranalysis AT ailawadhisikander retractedarticlesubsequentantimyelomatherapyafteridecabtagenevicleuceltreatmentinpatientswithrelapsedrefractorymultiplemyelomaasinglecenteranalysis |